Navigation Links
Study lays groundwork for norovirus anti-viral treatments
Date:7/22/2013

ANN ARBOR, Mich. An animal model of the human norovirus created at the University of Michigan Health System lays the groundwork for understanding the biology of the pesky virus and developing antiviral drug treatment.

Well-known as the virus that impacts cruise ship vacations, norovirus leads to misery on land too. The virus spreads quickly from person to person in any closed-in space, such as schools, nursing homes, or day-care centers.

"The first virus in this group was discovered in 1972 following a disease outbreak at a school in Norwalk, Ohio in 1968. Since then research has been underway to culture noroviruses in the laboratory and develop animal models," says lead researcher Christiane Wobus, Ph.D., assistant professor in the Department of Microbiology and Immunology at the University of Michigan Medical School.

An international group of scientists from the U.S. and Germany authored the study published in mBIO, a journal of the American Society of Microbiology.

"Norovirus research has been hampered by the absence of a norovirus cell culture and a genetically manipulable small animal model," Wobus says. "This new model gives us the tool to test potential antiviral compounds and may lay the foundation to culture these viruses in the lab."

The new model was developed by determining whether human noroviruses can infect "humanized" mice, this is mice containing human immune cells. These mice are widely used for study of the human immunodeficiency virus (HIV), a virus which can only infect human cells.

As a control researchers also included the same mice without human immune cells. In the study, both groups of mice were infected by human norovirus.

Additional studies determined that the immunodeficient background of this particular mouse strain is important in permitting human norovirus infection and identified macrophages, a vital immune cell in the body, as the cell type infected by the virus.

Very few particles of the virus can lead to infection. Estimates are as few as 18 particles can cause gastroenteritis (inflammation of the stomach and intestines) and lead to diarrhea, vomiting and stomach pain. In the U.S. norovirus causes approximately 21 million cases of acute gastroenteritis a year, and 800 deaths.

"Most people can cope with the symptoms, but deaths are more likely among the elderly mainly because of dehydration," Wobus says.

Only the common cold is more widespread than the norovirus, which can remain on surfaces for weeks, ready to cause more infections. Because it lacks a lipid envelope, norovirus is not susceptible to common disinfectants and alcohol-based sanitizers.

The economic impact of these infections is staggering with an economic cost for norovirus associated food-borne outbreaks alone of $5.8 billion in the U.S.

There is no vaccine for preventing norovirus infection and no drug to treat it. But the Centers for Disease Control and Prevention offers some tips for prevention, including handwashing with soap and water, washing fruits and vegetables properly and cleaning and disinfecting surfaces, and if you are sick not preparing food or caring for others.


'/>"/>

Contact: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert

Related medicine news :

1. Study links mental illness to early death in people with epilepsy
2. Study: EBV Mononucleosis Risk Increased by Smoking and Family Size; polyDNA Recommends Gene-Eden-VIR Against the Latent EBV
3. Overnights away from home affect childrens attachments, U.Va. study shows
4. DrugRisk Update: New Study Warns of Pradaxa Dangers as Lawsuits Increase
5. Attorneys at Michael D. Ponce & Associates React to a Study Concluding 40 That Nearly Percent of Designated Drivers Consume Alcohol
6. Study finds boys more likely to receive HPV vaccine when their mothers receive preventive care
7. CU study illuminates mortality differences between nondrinkers and light drinkers
8. Weight loss drug helps curb cocaine addictions, Penn study finds
9. Electronic health records help fight vaccine-preventable diseases, Columbia Nursing study finds
10. Study identifies a simple way to reduce healthcare costs
11. Study demonstrates link between reclassification of cannabis and cannabis psychosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... ... software products, today announced a strategic partnership with Lucidworks , the company ... and analyze their Fusion platform for building powerful enterprise search applications. , Element ...
(Date:1/24/2017)... ... 2017 , ... The Cruise Web Inc. was recognized today as ... Annual MSC True Partnerships’ Awards. , The 2016 MSC True Partnerships Awards ... based on overall business growth in revenue and guests and continuous partnership support and ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... that its annual Solutions Series of webinars will start January 31 with a ... a number of current health and benefits topics, including employee engagement, pricing transparency, ...
(Date:1/24/2017)... Rancho Santa Margarita, CA (PRWEB) , ... January 24, 2017 , ... ... career advancement platform for 21st century leadership, has named Hector M. Chavez, Manager, Employee ... cancer and diabetes treatment center - as its Hispanic Leader of the Month. City ...
(Date:1/24/2017)... Boston, MA (PRWEB) , ... January 24, 2017 ... ... What They Really Need to Thrive , Well-meaning studies such as the Fordham ... and schools can better serve top students, such as including gifted or high-achieving ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 2017 Italy Ultrasound Systems Market Outlook to 2022 ... Summary ... 2022", provides key market data on the Italy Ultrasound Systems ... volume (in units) and average prices (USD) within market segements ... Systems and Hand Held Ultrasound (HHU) Systems. The report ...
(Date:1/24/2017)... -- Span-America Medical Systems, Inc. (NASDAQ:  SPAN) announced that ... results on Thursday, February 2, 2017, after the close ... a conference call at 10:00 a.m. ET on Friday, ... for the first quarter ended December 31, 2016.  A live ... at www.spanamerica.com under Investor Relations on the ...
(Date:1/24/2017)... , Jan. 24, 2017  BioSpecifics ... a biopharmaceutical company that originated and continues ... in class collagenase-based product collagenase clostridium histolyticum, ... the U.S. and Xiapex ®  in Europe, today ... a corporate overview at the upcoming NobleCon13 ...
Breaking Medicine Technology: